LRRK2 and Parkinson disease: However, LRRK2 kinase activation may have much broader application as an underlying disease mechanism; for example, in carriers of additional LRRK2 variants of unknown clinical significance3, in idiopathic PD4 and carriers of the PD causing VPS35 D620N mutation5.